Fynx Capital (507962)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹21.79
Market Cap₹8.72 Cr
P/E Ratio0
ROCE-18.86%
ROE-52.61%
Dividend Yield0%
Profit Growth-82.22%
Debt/Equity
Sales Growth3,825%
52-Week Range₹3.28 — ₹21.79
SectorFinance
Book Value₹3

Strengths

Concerns

AI Analysis

When I look at Fynx Capital, I see a lot of price, but very little proof of value. The stock trades at ₹21.79, the top of its 52-week range, yet the latest quarter shows ₹2 crore in sales and a ₹1 crore net loss. That means every ₹2 of revenue produced ₹1 of loss. The reported P/E of zero is not a bargain signal; it is a warning that earnings are missing. Graham taught me to buy with a margin of safety. Here, book value is ₹3.00 and the market price is ₹21.79, over seven times book, while the company earns a ROE of -52.61%. The business is destroying shareholder capital, not compounding it. ROCE of -18.86% confirms poor use of capital. Sales growth of 3,825% sounds extraordinary, but it comes from a negligible base and profit growth is -82.22%. The Piotroski F-Score is 3/9, indicating weak fundamental health. As an NBFC, this firm must also prove asset quality and funding strength, but debt-to-equity and promoter holding are not disclosed, which is unacceptable for a lender. There is no dividend, and the FairStock Score is unavailable due to insufficient data. I cannot value what I cannot see. Mr. Market has marked the stock up from ₹2.42, but price history is not my safety net. This could be a turnaround in the making, but a turnaround calls for evidence of disciplined capital allocation and a path to positive profits. I see top-line noise and bottom-line losses. That is not investing; it is speculation. I will watch from the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer